$country= Comparative statistics by cancer registry - SurvCan

Comparative statistics by cancer registry

Registry: Comparative statistics by cancer site

Table4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group

(Busan, South Korea, 1996-2001 cases followed-up until 2003)

Click on cancer site (ICD-10 code) for comparison
SiteICD-10No. of casesMaleFemaleNumber of cases by age groupRelative survival by age group
5-year survival5-year survival
No.AbsRelNo.AbsRel<4545-5455-6465-7475+<4545-5455-6465-7475+
C01-02Tongue1449741.645.94757.761.528275723955.772.841.544.748.1
C03-06Oral cavity15610834.338.74855.459.3262347431785.442.554.415.428.6
C07-08Salivary gland864859.263.93876.679.631132414488.994.953.947.60.0
C09Tonsil595052.258.0922.223.86132018285.578.742.830.373.1
C10Other oropharynx343022.025.3427131020.029.725.425.30.0
C11Nasopharynx1348747.951.54754.855.945363416358.857.053.035.90.0
C12-13Hypopharynx878014.617.1724.524.85183421920.253.50.014.60.0
C15Oesophagus79070615.417.58422.926.0231303102408722.128.518.814.49.9
C16Stomach8683563740.745.3304639.442.1134816862701207787153.155.948.134.314.8
C17Small intestine1419113.014.95030.932.3182743381553.49.427.513.710.4
C18Colon1859100350.056.585647.751.926132555045726660.667.458.848.530.9
C19-20Rectum1882103148.955.485150.453.927041453645620653.759.863.453.023.4
C21Anus602746.254.53345.549.07915171243.2101.754.054.40.0
C22Liver650748288.49.316799.610.479717112096140050312.610.69.66.08.0
C23-24Gall bladder152471414.616.581014.616.07922344050927332.329.318.910.25.4
C25Pancreas10116004.35.14117.28.07115432830815017.85.26.74.44.9
C30-31Nose/Sinuses1036733.338.03631.434.1131935261053.920.132.945.031.4
C32Larynx47542251.458.45335.940.622951721424461.065.963.045.938.2
C33-34Lung479635189.911.3127812.013.42606381537162573623.018.114.47.36.6
C37-38Other thoracic organs14810130.332.14737.039.4493033241250.834.423.330.40.0
C40-41Bone19610857.259.18846.247.8123212717868.543.038.117.80.0
C43Melanoma skin864738.242.73942.448.1211423171137.155.042.767.727.5
C44Other skin42321171.082.421283.494.564651091107593.395.386.784.686.5
C45Mesothelioma301520.021.71511.411.76788116.729.627.10.00.0
C47+C49Connective tissue25014441.043.610646.648.51044654351156.254.839.123.417.7
C50Breast26421969.789.5262379.781.610798714851733483.981.281.373.952.5
C51Vulva252562.167.25558278.2101.562.358.40.0
C53Cervix2264226474.176.39125954372467486.179.173.851.716.3
C54Corpus uteri26526576.078.376877228291.179.571.061.00.0
C56Ovary62262256.057.7239137128853378.860.242.826.227.0
C58Placenta303086.386.824600087.584.40.00.00.0
C60Penis292973.588.84686525.665.3109.684.6166.7
C61Prostate43043041.954.561510017613345.425.760.964.239.6
C62Testis555574.074.949330078.534.60.00.00.0
C64Kidney70647755.160.222960.964.51411622211453777.369.954.857.615.7
C65Renal pelvis745644.951.71844.448.0810292160.062.556.739.20.0
C66Ureter774850.759.52945.650.4210232517101.856.876.527.253.2
C67Urinary bladder99980060.870.419956.464.08915230429016481.989.174.460.446.2
C69Eye362055.057.71665.567.322164376.3106.671.20.00.0
C70-72Brain & nervous system52028435.036.023640.041.02759177581951.833.416.416.019.8
C73Thyroid117520681.386.796991.394.05542651991223598.196.292.777.832.6
C74-75Adrenal gland, other endocrine563645.045.62064.465.641564063.520.317.929.70.0
C81Hodgkin lymphoma523259.763.32065.767.72211117194.347.532.348.50.0
C82-85+C96Non-Hodgkin lymphoma78544042.445.834544.346.72451472001355856.947.348.927.527.3
C90Multiple myeloma18210010.311.48212.313.3103568581127.618.315.55.70.0
C91Lymphoid leukaemia22214237.437.78049.750.1183151410048.123.819.60.00.0
C92-94Myeloid leukaemia48027325.626.820728.128.82706085501536.029.916.86.80.0
C95Leukaemia unspecified442213.617.72213451390.00.00.09.516.7


Graphs:


Other tables available for this registry:
- Table1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Busan, South Korea, 1996-2001 cases followed-up until 2003)
- Table2b: Number and proportion of cases by vital status and median follow-up (in months) by site (Busan, South Korea, 1996-2001 cases followed-up until 2003)
- Table3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Busan, South Korea, 1996-2001 cases followed-up until 2003)
- Table4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Busan, South Korea, 1996-2001 cases followed-up until 2003)




Registry chapter:


Consult the chapter in Cancer survival in developping countries (Volume II)